Jacobson Pharma Corporation Limited (HKG:2633)

Hong Kong · Delayed Price · Currency is HKD

0.9700

+0.0050 (0.52%)

Sep 18, 2026, 3:59 PM HKT

Market Cap	1.93B -34.2%
Revenue (ttm)	1.57B -0.5%
Net Income	301.62M +0.3%
EPS	0.15 -0.3%
Shares Out	2.00B
PE Ratio	6.39
Forward PE	6.27
Dividend	0.09 (9.28%)
Ex-Dividend Date	Sep 7, 2026

Volume	694,000
Open	0.9800
Previous Close	0.9650
Day's Range	0.9600 - 0.9800
52-Week Range	0.9500 - 1.5100
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2026

About HKG:2633

Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally. The company offers a portfolio of generic drugs for various therapeutic classes, such as cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatologicals, and anti-allergics in oral solid and liquid, external liquid, semi-solid, steril... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2016

Employees 1,768

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2633

Full Company Profile

Financial Performance

In fiscal year 2026, HKG:2633's revenue was 1.57 billion, a decrease of -0.47% compared to the previous year's 1.58 billion. Earnings were 301.62 million, an increase of 0.26%.

Financial Statements